TAF
RVMD icon

Tredje AP-fonden’s Revolution Medicines RVMD Stock Holding History

Tredje AP-fonden’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06M Buy
27,000
+12,098
+81% +$1.77M 0.02% 384
2026
Q1 		$1.45M Buy
+14,902
New +$1.5M 0.01% 536

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Tredje AP-fonden's RVMD Position: Q2 2026 in Review

Tredje AP-fonden increased its Revolution Medicines (RVMD) stake by 81% in Q2 2026, buying an estimated $1.77M and bringing the position to 27,000 shares worth $5.06M. The position accounts for 0.02% of the portfolio, ranked #384.

Tredje AP-fonden first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Tredje AP-fonden held 27,000 shares of Revolution Medicines worth $5.06M as of Q2 2026.
  • Tredje AP-fonden bought 12,098 Revolution Medicines shares in Q2 2026, an estimated $1.77M.
  • Revolution Medicines made up 0.02% of Tredje AP-fonden's portfolio in Q2 2026, its #384 holding.
  • Tredje AP-fonden first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.